Synopsis of recent research by authors named "Shiliang Ma"
- Shiliang Ma's recent research highlights the role of inhibitory immune receptors, specifically VSTM1, and their interactions with galectin-1 in regulating neutrophil function, suggesting potential therapeutic targets for autoimmune diseases like systemic lupus erythematosus (SLE).
- The development of novel IL-2 variants that selectively activate regulatory T cells showcases an innovative approach to addressing autoimmunity through enhanced signaling pathways, presenting new avenues for treatment strategies.
- Ma's investigations extend to the field of materials science, including studies on chloride ion diffusion in coral aggregate seawater concrete, indicating a diverse research portfolio that encompasses both biomedical and environmental applications.
